Maryland Heights, MO, April 21, 2017 --(PR.com
)-- As many molecular techniques and technologies such as polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization technique, microarray, sequencing, etc. have made their expected transitions into the clinical arena, molecular diagnostics has become an integral part of clinical applications such as genomics, proteomics, oncology, microbiology, blood screening, prenatal and newborn screening and women’s health. Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. These days, molecular diagnostics kits are being widely adopted for testing genetic diseases, cancer, hepatitis virus and hospital acquired infections, as well as for blood donor screening test for hepatitis and HIV.
Browse Molecular Diagnostics Market by Technologies (PCR, FISH, NGS, and Biochips) and Applications (Genomics, Proteomics, Oncology, Microbiology, Blood Screening, Prenatal and Newborn Screening and Women’s Health) and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/molecular-diagnostics-market/
The global molecular diagnostics market report estimates the market size (Revenue USD million - 2014 to 2021) and composition of this market based on underlying technologies and its applications, and also forecasts growth trends (CAGR% - 2017 to 2021). The technology market segment is divided by polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization technique, microarray, sequencing and others, while the application market segment is classified into infectious diseases, blood donor screening and genomics.
The global molecular diagnostics market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global molecular diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global molecular diagnostics market and included in this report are Abbott Laboratories, Becton Dickinson & Company, Cepheid, Roche Diagnostics and others.
1.1. Biochips and Microfluidics
1.2. Hybridization (ISH and FISH)
1.3. Mass Spectrometry
1.4. Next Generation Sequencing
1.5. Polymerase Chain Reaction
1.6. Transcription Mediated Amplification (TMA)
2.1. Blood Screening
2.3. Infectious Disease Testing
2.6. Prenatal and Newborn Screening
2.7. Women’s Health
3. Geography (Region, Country)
3.1 North America (U.S., Canada)
3.2 Latin America (Brazil, Mexico, Rest of LA)
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4 Asia Pacific (Japan, China, India, Rest of APAC)
3.5 Rest of the World
4. Company Profiles
4.1. Abbott Laboratories
4.2. Affymetrix, Inc.
4.3. Agilent Technologies, Inc.
4.4. Alere, Inc.
4.5. bioMérieux SA
4.6. Bio-Rad Laboratories, Inc.
4.7. Cepheid, Inc.
4.8. Danaher Corporation
4.9. F. Hoffmann-La Roche Ltd.
4.10. Hologic, Inc.
4.11. Meridian Bioscience, Inc.
4.12. PerkinElmer, Inc.
4.13. Qiagen N.V.
4.14. Randox Laboratories, Ltd.
4.15. Siemens AG
4.16. Thermo Fisher Scientific, Inc.
To request the Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/molecular-diagnostics-market/
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043